Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 26, 2025
Accession Number:
0001193125-25-044183
Submission Type:
POS AM
CIK:
0001885522
Company Name:
Neumora Therapeutics, Inc.
File Number:
333-282460